VolitionRx Ltd Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Warrants And Options (Details Narrative)

Warrants And Options (Details Narrative) - USD ($)				1 Months Ended		12 Months Ended
Warrants And Options (Details Narrative) - USD ($)	Nov. 13, 2018	Aug. 10, 2018	Sep. 08, 2017	Sep. 28, 2018	Jun. 15, 2018	Dec. 31, 2018	Dec. 31, 2017	Aug. 05, 2016
Outstanding warrants to purchase common stock	29,392
Extend expiration date	<p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2019</font></p>
Additional warrant expense	$ 14,198
Proceeds from warrants exercised						$ 717,917
Weighted average remaining contractual life						7 months 17 days
Unrecognized compensation cost of non-vested stock options						$ 150,354
Unrecognized compensation cost of non-vested warrants recognition period						8 months 26 days
Aggregate Intrinsic value						$ 0
Stock based compensation						$ 2,570,095	$ 2,435,088
Common stock shares reserved for future issuance						799,000
Private Placement [Member] \| Cotterford [Member]
Warrants issued to purchase common shares		5,000,000
Exercise price		$ 3.00
Expiration date		Aug. 10, 2019
Warrant [Member]
Exercised						(333,528)
Expired						(290,535)
Outstanding, December 31, 2018						$ 2.88	$ 2.36
Unrecognized compensation cost of non-vested stock options						$ 17,012
Unrecognized compensation cost of non-vested warrants recognition period						2 years
Aggregate Intrinsic value						$ 0
Warrant expense						$ 22,776	$ 54,510
Stock option [Member]
Common stock purchase				25,000
Exercise price				$ 4.00
Stock per share price				$ 2.59
Expected term				6 years
Volatility				77.59%
Risk free rate				3.01%
Stock option vesting date				Sep. 28, 2019
Term				5 years
Fair market value				$ 39,733
Outstanding options amendement description						<p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">(i) the expiration date for outstanding options to purchase up to an aggregate of 645,000 shares of the Company’s common stock, granted on August 18, 2014 under the 2011 Plan, was extended for both vesting installments from four (4) years from the vesting date of each installment to a single expiration date of August 18, 2020,</font></p>
Additional options expense				209,308
Stock option One [Member]
Outstanding options amendement description						<p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">(ii) the expiration date for outstanding options to purchase up to an aggregate of 20,000 shares of the Company’s common stock, granted on May 18, 2015 under the 2011 Plan, was extended from four (4) years after the vesting date to May 18, 2021,</font></p>
Stock option Two [Member]
Outstanding options amendement description						<p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">(iii) the expiration date for outstanding options to purchase up to an aggregate of 317,000 shares of the Company’s common stock, granted July 23, 2015 under the 2011 Plan, was extended from four (4) years after vesting to five years and six months after vesting, or July 23, 2021.</font></p>
Stock option [Member]
Common stock shares increased for future issuance								750,000
Common stock shares reserved for future issuance								1,750,000
Stock option [Member] \| Minimum [Member]
Stock options warrants			750,000		750,000
Stock option [Member] \| Maximum [Member]
Stock options warrants			2,500,000		3,250,000
Stock option [Member] \| 2011 Plan Or 2015 [Member]
Weighted average remaining contractual life						3 years 6 months 10 days
Weighted average exercise price						$ 4.09
Stock option [Member] \| On January 23, 2018 [Member]
Common stock purchase						780,000
Exercise price						$ 4.00
Stock per share price						$ 3.75
Expected term						6 years
Volatility						75.40%
Risk free rate						2.55%
Stock option vesting date						Jan. 23, 2019
Term						5 years
Fair market value						$ 1,930,265